[Obtaining blood components in blood banks].
After the first successful blood transfusion, different difficulties of a liquid tissue were overcome; this liquid required special conditions to keep its characteristics with minimal alterations and,...
Maladies virales : Questions médicales fréquentes
Questions fréquentes et termes MeSH associés
Diagnostic 5
#1
Comment diagnostique-t-on une infection virale ?
Le diagnostic repose sur des tests sanguins, des cultures virales et des analyses cliniques.
#2
Quels tests sont utilisés pour le VIH ?
Les tests de dépistage incluent les tests ELISA et les tests de charge virale.
#3
Les symptômes peuvent-ils indiquer un virus spécifique ?
Oui, certains symptômes comme la fièvre ou la toux peuvent orienter vers un virus particulier.
#4
Quelle est l'importance des tests PCR ?
Les tests PCR détectent l'ADN ou l'ARN viral, permettant un diagnostic précoce et précis.
#5
Peut-on diagnostiquer une grippe sans test ?
Oui, un médecin peut diagnostiquer la grippe par l'examen clinique et les symptômes.
Symptômes 5
#1
Quels sont les symptômes courants des maladies virales ?
Fièvre, fatigue, douleurs musculaires, toux et maux de tête sont fréquents.
#2
La diarrhée est-elle un symptôme viral ?
Oui, certaines infections virales, comme le rotavirus, peuvent provoquer des diarrhées.
#3
Les éruptions cutanées sont-elles liées aux virus ?
Oui, des virus comme la varicelle peuvent provoquer des éruptions cutanées.
#4
Comment la fatigue se manifeste-t-elle dans les infections virales ?
La fatigue peut être intense et persistante, souvent due à la réponse immunitaire.
#5
Les symptômes varient-ils selon le virus ?
Oui, chaque virus peut provoquer un ensemble de symptômes distincts.
Prévention 5
#1
Comment prévenir les infections virales ?
Se laver les mains, éviter les contacts étroits et se faire vacciner sont essentiels.
#2
Les vaccins sont-ils sûrs ?
Oui, les vaccins sont rigoureusement testés pour leur sécurité et leur efficacité.
#3
Le port du masque aide-t-il à prévenir les virus ?
Oui, le port du masque réduit la transmission des virus respiratoires.
#4
Quelles sont les recommandations pour les voyages ?
Se faire vacciner et éviter les foules sont recommandés lors de voyages.
#5
L'hygiène alimentaire peut-elle prévenir les infections ?
Oui, une bonne hygiène alimentaire réduit le risque d'infections virales d'origine alimentaire.
Traitements 5
#1
Quels traitements sont disponibles pour les infections virales ?
Les traitements incluent des antiviraux, des soins symptomatiques et des vaccins.
#2
Les antibiotiques sont-ils efficaces contre les virus ?
Non, les antibiotiques ne traitent que les infections bactériennes, pas virales.
#3
Comment les antiviraux fonctionnent-ils ?
Les antiviraux inhibent la réplication virale, réduisant la gravité et la durée de l'infection.
#4
Les vaccins préviennent-ils les maladies virales ?
Oui, les vaccins stimulent le système immunitaire pour prévenir certaines infections virales.
#5
Quels sont les traitements pour l'hépatite virale ?
Les traitements incluent des antiviraux spécifiques et des soins de soutien.
Complications 5
#1
Quelles complications peuvent survenir avec la grippe ?
Des complications comme la pneumonie et l'aggravation des maladies chroniques peuvent survenir.
#2
Les infections virales peuvent-elles causer des maladies chroniques ?
Oui, certaines infections virales peuvent entraîner des maladies chroniques comme l'hépatite.
#3
Quelles sont les complications du VIH ?
Le VIH peut entraîner des infections opportunistes et des cancers liés à l'immunodéficience.
#4
Les virus peuvent-ils affecter le système nerveux ?
Oui, des virus comme le virus de la rage peuvent causer des atteintes neurologiques graves.
#5
Quelles complications peuvent survenir après une infection par le COVID-19 ?
Des complications comme le syndrome post-COVID, des problèmes respiratoires et neurologiques peuvent survenir.
Facteurs de risque 5
#1
Quels sont les facteurs de risque pour les infections virales ?
Les facteurs incluent un système immunitaire affaibli, le vieillissement et le manque de vaccination.
#2
Le stress augmente-t-il le risque d'infections virales ?
Oui, le stress peut affaiblir le système immunitaire, augmentant le risque d'infections.
#3
Les enfants sont-ils plus à risque d'infections virales ?
Oui, les enfants ont un système immunitaire en développement, les rendant plus vulnérables.
#4
Le tabagisme influence-t-il les infections virales ?
Oui, le tabagisme peut affaiblir les défenses immunitaires et augmenter le risque d'infections.
#5
Les voyages augmentent-ils le risque d'infections virales ?
Oui, les voyages peuvent exposer à de nouveaux virus et augmenter le risque d'infection.
Contenu validé par Dr Olivier Menir
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 26/04/2025
Contenu vérifié selon les dernières recommandations médicales
Sous-catégories
83 au total
└─
Infections à arbovirus
Arbovirus InfectionsD001102 -
C01.925.081
└─
Infections à virus à ADN
DNA Virus InfectionsD004266 -
C01.925.256
└─
Infections à virus à ARN
RNA Virus InfectionsD012327 -
C01.925.782
└─
Infections à virus lents
Slow Virus DiseasesD012897 -
C01.925.839
└─
Infections à virus oncogènes
Tumor Virus InfectionsD014412 -
C01.925.928
└─└─
Infections à Adenoviridae
Adenoviridae InfectionsD000257 -
C01.925.256.076
└─└─
Infections à Circoviridae
Circoviridae InfectionsD018173 -
C01.925.256.200
└─└─
Infections à Hepadnaviridae
Hepadnaviridae InfectionsD018347 -
C01.925.256.430
└─└─
Infections à Herpesviridae
Herpesviridae InfectionsD006566 -
C01.925.256.466
└─└─
Infections à Parvoviridae
Parvoviridae InfectionsD010322 -
C01.925.256.700
└─└─
Infections à polyomavirus
Polyomavirus InfectionsD027601 -
C01.925.256.721
└─└─
Infections à Poxviridae
Poxviridae InfectionsD011213 -
C01.925.256.743
└─└─
Infections à Arenaviridae
Arenaviridae InfectionsD001117 -
C01.925.782.082
└─└─
Infections à Astroviridae
Astroviridae InfectionsD019350 -
C01.925.782.105
└─└─
Infections à Birnaviridae
Birnaviridae InfectionsD018175 -
C01.925.782.123
└─└─
Infections à Bunyaviridae
Bunyaviridae InfectionsD002044 -
C01.925.782.147
└─└─
Infections à Caliciviridae
Caliciviridae InfectionsD017250 -
C01.925.782.160
└─└─
Infections à Flaviviridae
Flaviviridae InfectionsD018178 -
C01.925.782.350
└─└─
Fièvres hémorragiques virales
Hemorrhagic Fevers, ViralD006482 -
C01.925.782.417
└─└─
Infections à Mononegavirales
Mononegavirales InfectionsD018701 -
C01.925.782.580
└─└─
Infections à Nidovirales
Nidovirales InfectionsD030341 -
C01.925.782.600
└─└─
Infections à Orthomyxoviridae
Orthomyxoviridae InfectionsD009976 -
C01.925.782.620
└─└─
Infections à Picornaviridae
Picornaviridae InfectionsD010850 -
C01.925.782.687
└─└─
Infections à Reoviridae
Reoviridae InfectionsD012088 -
C01.925.782.791
└─└─
Infections à Retroviridae
Retroviridae InfectionsD012192 -
C01.925.782.815
└─└─
Infections à Togaviridae
Togaviridae InfectionsD014036 -
C01.925.782.930
└─└─
Infections à virus Epstein-Barr
Epstein-Barr Virus InfectionsD020031 -
C01.925.928.313
└─└─└─
Infections humaines à adénovirus
Adenovirus Infections, HumanD000258 -
C01.925.256.076.045
└─└─└─
Infections à cytomégalovirus
Cytomegalovirus InfectionsD003586 -
C01.925.256.466.245
└─└─└─
Infections à roséolovirus
Roseolovirus InfectionsD019349 -
C01.925.256.466.850
└─└─└─
Infection à virus varicelle-zona
Varicella Zoster Virus InfectionD000073618 -
C01.925.256.466.930
└─└─└─
Cowpox
CowpoxD015605 -
C01.925.256.743.175
└─└─└─
Variole
SmallpoxD012899 -
C01.925.256.743.826
└─└─└─
Vaccine
VacciniaD014615 -
C01.925.256.743.929
└─└─└─
Infections à hantavirus
Hantavirus InfectionsD018778 -
C01.925.782.147.420
└─└─└─
Fièvre à phlébotomes
Phlebotomus FeverD010217 -
C01.925.782.147.700
└─└─└─
Syndrome de fièvre sévère avec thrombocytopénie
Severe Fever with Thrombocytopenia SyndromeD000085142 -
C01.925.782.147.905
└─└─└─
Infections à flavivirus
Flavivirus InfectionsD018177 -
C01.925.782.350.250
└─└─└─
Infections à pestivirus
Pestivirus InfectionsD018182 -
C01.925.782.350.675
└─└─└─
Dengue
DengueD003715 -
C01.925.782.417.214
└─└─└─
Fièvre hémorragique avec syndrome rénal
Hemorrhagic Fever with Renal SyndromeD006480 -
C01.925.782.417.300
└─└─└─
Fièvre hémorragique américaine
Hemorrhagic Fever, AmericanD006478 -
C01.925.782.417.400
└─└─└─
Fièvre hémorragique de Crimée-Congo
Hemorrhagic Fever, CrimeanD006479 -
C01.925.782.417.412
└─└─└─
Fièvre hémorragique d'Omsk
Hemorrhagic Fever, OmskD006481 -
C01.925.782.417.435
└─└─└─
Maladie de la forêt Kyasanur
Kyasanur Forest DiseaseD007733 -
C01.925.782.417.475
└─└─└─
Fièvre de Lassa
Lassa FeverD007835 -
C01.925.782.417.505
└─└─└─
Fièvre jaune
Yellow FeverD015004 -
C01.925.782.417.881
└─└─└─
Infections à Filoviridae
Filoviridae InfectionsD018702 -
C01.925.782.580.250
└─└─└─
Infections à Paramyxoviridae
Paramyxoviridae InfectionsD018184 -
C01.925.782.580.600
└─└─└─
Infections à Rhabdoviridae
Rhabdoviridae InfectionsD018353 -
C01.925.782.580.830
└─└─└─
Infections à artérivirus
Arterivirus InfectionsD018174 -
C01.925.782.600.100
└─└─└─
Infections à Coronaviridae
Coronaviridae InfectionsD003333 -
C01.925.782.600.550
└─└─└─
Infections à cardiovirus
Cardiovirus InfectionsD018188 -
C01.925.782.687.150
└─└─└─
Infections à entérovirus
Enterovirus InfectionsD004769 -
C01.925.782.687.359
└─└─└─
Fièvre à tiques du Colorado
Colorado Tick FeverD003121 -
C01.925.782.791.482
└─└─└─
Infections à rotavirus
Rotavirus InfectionsD012400 -
C01.925.782.791.814
└─└─└─
Infections à lentivirus
Lentivirus InfectionsD016180 -
C01.925.782.815.616
└─└─└─
Infections à alphavirus
Alphavirus InfectionsD018354 -
C01.925.782.930.100
└─└─└─
Infections à rubivirus
Rubivirus InfectionsD018355 -
C01.925.782.930.700
└─└─└─└─
Varicelle
ChickenpoxD002644 -
C01.925.256.466.930.250
└─└─└─└─
Zona
Herpes ZosterD006562 -
C01.925.256.466.930.750
└─└─└─└─
Infection par le virus Zika
Zika Virus InfectionD000071243 -
C01.925.782.350.250.990
└─└─└─└─
Dengue sévère
Severe DengueD019595 -
C01.925.782.417.214.200
└─└─└─└─
Fièvre hémorragique à virus Ebola
Hemorrhagic Fever, EbolaD019142 -
C01.925.782.580.250.400
└─└─└─└─
Infections à avulavirus
Avulavirus InfectionsD045463 -
C01.925.782.580.600.080
└─└─└─└─
Infections à hénipavirus
Henipavirus InfectionsD045464 -
C01.925.782.580.600.400
└─└─└─└─
Infections à virus morbilleux
Morbillivirus InfectionsD018185 -
C01.925.782.580.600.500
└─└─└─└─
Infections à pneumovirus
Pneumovirus InfectionsD018186 -
C01.925.782.580.600.550
└─└─└─└─
Infections à respirovirus
Respirovirus InfectionsD010253 -
C01.925.782.580.600.600
└─└─└─└─
Infections à rubulavirus
Rubulavirus InfectionsD019351 -
C01.925.782.580.600.680
└─└─└─└─
Rage (maladie)
RabiesD011818 -
C01.925.782.580.830.750
└─└─└─└─
Infections à coronavirus
Coronavirus InfectionsD018352 -
C01.925.782.600.550.200
└─└─└─└─
Infections à torovirus
Torovirus InfectionsD018176 -
C01.925.782.600.550.800
└─└─└─└─
Infections à virus coxsackie
Coxsackievirus InfectionsD003384 -
C01.925.782.687.359.213
└─└─└─└─
Infections à échovirus
Echovirus InfectionsD004457 -
C01.925.782.687.359.347
└─└─└─└─
Fièvre chikungunya
Chikungunya FeverD065632 -
C01.925.782.930.100.184
└─└─└─└─
Rubéole
RubellaD012409 -
C01.925.782.930.700.700
└─└─└─└─└─
Zona sine herpete
Zoster Sine HerpeteD031368 -
C01.925.256.466.930.750.970
└─└─└─└─└─
Rougeole
MeaslesD008457 -
C01.925.782.580.600.500.500
└─└─└─└─└─
Infections à virus respiratoire syncytial
Respiratory Syncytial Virus InfectionsD018357 -
C01.925.782.580.600.550.750
└─└─└─└─└─
Syndrome mains-pieds-bouche
Hand, Foot and Mouth DiseaseD006232 -
C01.925.782.687.359.213.331
└─└─└─└─└─
Pleurodynie épidémique
Pleurodynia, EpidemicD011000 -
C01.925.782.687.359.213.737
└─└─└─└─└─
Herpangine
HerpanginaD006557 -
C01.925.782.687.359.347.500
Auteurs principaux
Benedikt B Kaufer
3 publications dans cette catégorie
Affiliations :
- Institut für Virologie, Zentrum für Infektionsmedizin, Freie Universität Berlin, Berlin, Germany.
Publications dans "Maladies virales" :
-
The Marek's Disease Virus Unique Gene MDV082 Is Dispensable for Virus Replication but Contributes to a Rapid Disease Onset.
Journal of virology 2021-07-12
-
The Role of Marek's Disease Virus UL12 and UL29 in DNA Recombination and the Virus Lifecycle.
Viruses 2019-01-28
-
Replication of Marek's Disease Virus Is Dependent on Synthesis of
Journal of virology 2019-06-14
Ian Crozier
2 publications dans cette catégorie
Affiliations :
- Integrated Research Facility at Fort Detrick, Clinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research supported by the National Cancer Institute, Frederick, MD, USA.
Publications dans "Maladies virales" :
-
Ebola virus disease.
Nature reviews. Disease primers 2020-02-20
-
Ebola Virus Transmission Initiated by Relapse of Systemic Ebola Virus Disease.
The New England journal of medicine
Nicole M Nemeth
2 publications dans cette catégorie
Affiliations :
- Southeastern Cooperative Wildlife Disease Study, University of Georgia, 589 D.W. Brooks Drive, Athens, Georgia 30602, USA.
- Department of Pathology, University of Georgia, 501 D.W. Brooks Drive, Athens, Georgia 30602, USA.
Publications dans "Maladies virales" :
-
Lymphoproliferative Disease Virus and Reticuloendotheliosis Virus Detection and Disease in Wild Turkeys (Meleagris gallopavo).
Journal of wildlife diseases 2023-11-16
-
Lymphoproliferative Disease Virus in Wild Turkeys (
Avian diseases
Yu You
2 publications dans cette catégorie
Affiliations :
- Institut für Virologie, Zentrum für Infektionsmedizin, Freie Universität Berlin, Berlin, Germany.
Publications dans "Maladies virales" :
Luca D Bertzbach
2 publications dans cette catégorie
Affiliations :
- Institut für Virologie, Zentrum für Infektionsmedizin, Freie Universität Berlin, Berlin, Germany.
- Leibniz Institut für Experimentelle Virologie (HPI), Forschungsabteilung Virale Transformation, Hamburg, Germany.
Publications dans "Maladies virales" :
Bairong Shen
2 publications dans cette catégorie
Affiliations :
- Institutes for Systems Genetics, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, Sichuan, China. bairong.shen@scu.edu.cn.
Publications dans "Maladies virales" :
-
Predicting the Disease Severity of Virus Infection.
Advances in experimental medicine and biology
-
In Silico Drug Discovery for Treatment of Virus Diseases.
Advances in experimental medicine and biology
Van T Tong
2 publications dans cette catégorie
Affiliations :
- From Instituto Nacional de Salud (M.L.O., M.G., M.M., A.J.R, A.R., L.P., G.A., S.G., F.P., O.P.), Bogota, Colombia; and the Centers for Disease Control and Prevention (V.T.T., D.V., S.M.G., S.C.T., C.M.W., J.D.T., J.M.V., D.M.D., M.A.H.) and the Department of Gynecology and Obstetrics, Emory University School of Medicine (D.J.J.), Atlanta.
Publications dans "Maladies virales" :
-
Zika Virus Disease and Pregnancy Outcomes in Colombia.
The New England journal of medicine
-
Zika Virus Disease in Colombia - Preliminary Report.
The New England journal of medicine 2016-06-15
Diana Valencia
2 publications dans cette catégorie
Affiliations :
- From Instituto Nacional de Salud (M.L.O., M.G., M.M., A.J.R, A.R., L.P., G.A., S.G., F.P., O.P.), Bogota, Colombia; and the Centers for Disease Control and Prevention (V.T.T., D.V., S.M.G., S.C.T., C.M.W., J.D.T., J.M.V., D.M.D., M.A.H.) and the Department of Gynecology and Obstetrics, Emory University School of Medicine (D.J.J.), Atlanta.
Publications dans "Maladies virales" :
-
Zika Virus Disease and Pregnancy Outcomes in Colombia.
The New England journal of medicine
-
Zika Virus Disease in Colombia - Preliminary Report.
The New England journal of medicine 2016-06-15
Marcela Mercado
2 publications dans cette catégorie
Affiliations :
- From Instituto Nacional de Salud (M.L.O., M.G., M.M., A.J.R, A.R., L.P., G.A., S.G., F.P., O.P.), Bogota, Colombia; and the Centers for Disease Control and Prevention (V.T.T., D.V., S.M.G., S.C.T., C.M.W., J.D.T., J.M.V., D.M.D., M.A.H.) and the Department of Gynecology and Obstetrics, Emory University School of Medicine (D.J.J.), Atlanta.
Publications dans "Maladies virales" :
-
Zika Virus Disease and Pregnancy Outcomes in Colombia.
The New England journal of medicine
-
Zika Virus Disease in Colombia - Preliminary Report.
The New England journal of medicine 2016-06-15
Lissethe Pardo
2 publications dans cette catégorie
Affiliations :
- From Instituto Nacional de Salud (M.L.O., M.G., M.M., A.J.R, A.R., L.P., G.A., S.G., F.P., O.P.), Bogota, Colombia; and the Centers for Disease Control and Prevention (V.T.T., D.V., S.M.G., S.C.T., C.M.W., J.D.T., J.M.V., D.M.D., M.A.H.) and the Department of Gynecology and Obstetrics, Emory University School of Medicine (D.J.J.), Atlanta.
Publications dans "Maladies virales" :
-
Zika Virus Disease and Pregnancy Outcomes in Colombia.
The New England journal of medicine
-
Zika Virus Disease in Colombia - Preliminary Report.
The New England journal of medicine 2016-06-15
Denise J Jamieson
2 publications dans cette catégorie
Affiliations :
- From Instituto Nacional de Salud (M.L.O., M.G., M.M., A.J.R, A.R., L.P., G.A., S.G., F.P., O.P.), Bogota, Colombia; and the Centers for Disease Control and Prevention (V.T.T., D.V., S.M.G., S.C.T., C.M.W., J.D.T., J.M.V., D.M.D., M.A.H.) and the Department of Gynecology and Obstetrics, Emory University School of Medicine (D.J.J.), Atlanta.
Publications dans "Maladies virales" :
-
Zika Virus Disease and Pregnancy Outcomes in Colombia.
The New England journal of medicine
-
Zika Virus Disease in Colombia - Preliminary Report.
The New England journal of medicine 2016-06-15
Oscar Pacheco
2 publications dans cette catégorie
Affiliations :
- From Instituto Nacional de Salud (M.L.O., M.G., M.M., A.J.R, A.R., L.P., G.A., S.G., F.P., O.P.), Bogota, Colombia; and the Centers for Disease Control and Prevention (V.T.T., D.V., S.M.G., S.C.T., C.M.W., J.D.T., J.M.V., D.M.D., M.A.H.) and the Department of Gynecology and Obstetrics, Emory University School of Medicine (D.J.J.), Atlanta.
Publications dans "Maladies virales" :
-
Zika Virus Disease and Pregnancy Outcomes in Colombia.
The New England journal of medicine
-
Zika Virus Disease in Colombia - Preliminary Report.
The New England journal of medicine 2016-06-15
Margaret A Honein
2 publications dans cette catégorie
Affiliations :
- From Instituto Nacional de Salud (M.L.O., M.G., M.M., A.J.R, A.R., L.P., G.A., S.G., F.P., O.P.), Bogota, Colombia; and the Centers for Disease Control and Prevention (V.T.T., D.V., S.M.G., S.C.T., C.M.W., J.D.T., J.M.V., D.M.D., M.A.H.) and the Department of Gynecology and Obstetrics, Emory University School of Medicine (D.J.J.), Atlanta.
Publications dans "Maladies virales" :
-
Zika Virus Disease and Pregnancy Outcomes in Colombia.
The New England journal of medicine
-
Zika Virus Disease in Colombia - Preliminary Report.
The New England journal of medicine 2016-06-15
Shevin T Jacob
1 publication dans cette catégorie
Affiliations :
- Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK.
- Global Health Security Department, Infectious Diseases Institute, Makerere University, Kampala, Uganda.
Publications dans "Maladies virales" :
-
Ebola virus disease.
Nature reviews. Disease primers 2020-02-20
William A Fischer
1 publication dans cette catégorie
Affiliations :
- Department of Medicine, Division of Pulmonary Disease and Critical Care Medicine, Chapel Hill, NC, USA.
Publications dans "Maladies virales" :
-
Ebola virus disease.
Nature reviews. Disease primers 2020-02-20
Angela Hewlett
1 publication dans cette catégorie
Affiliations :
- Nebraska Biocontainment Unit, Division of Infectious Diseases, University of Nebraska Medical Center, Omaha, NE, USA.
Publications dans "Maladies virales" :
-
Ebola virus disease.
Nature reviews. Disease primers 2020-02-20
Colleen S Kraft
1 publication dans cette catégorie
Affiliations :
- Microbiology Section, Emory Medical Laboratory, Emory University School of Medicine, Atlanta, GA, USA.
Publications dans "Maladies virales" :
-
Ebola virus disease.
Nature reviews. Disease primers 2020-02-20
Marc-Antoine de La Vega
1 publication dans cette catégorie
Affiliations :
- Department of Microbiology, Immunology & Infectious Diseases, Université Laval, Quebec City, QC, Canada.
Publications dans "Maladies virales" :
-
Ebola virus disease.
Nature reviews. Disease primers 2020-02-20
Moses J Soka
1 publication dans cette catégorie
Affiliations :
- Partnership for Ebola Virus Disease Research in Liberia, Monrovia Medical Units ELWA-2 Hospital, Monrovia, Liberia.
Publications dans "Maladies virales" :
-
Ebola virus disease.
Nature reviews. Disease primers 2020-02-20
Victoria Wahl
1 publication dans cette catégorie
Affiliations :
- National Biodefense Analysis and Countermeasures Center, Fort Detrick, Frederick, MD, USA.
Publications dans "Maladies virales" :
-
Ebola virus disease.
Nature reviews. Disease primers 2020-02-20
Sources (10000 au total)
Evaluation of the treatment volume and removal rate of Rheocarna: A novel adsorption-type blood purification device for patients with chronic limb-threatening ischemia.
Chronic limb-threatening ischemia (CLTI) is a clinical syndrome defined by peripheral arterial disease (PAD) combined with rest pain, gangrene, or leg ulceration for longer than two weeks resulting in... To evaluate the applicability of this treatment procedure, we compared the removal rates of Fib and LDL following Rheocarna therapy using various blood treatment volumes (6, 10.5, and 19.5 L).... Fib and LDL removal rates were about 20% and 15%-25% per treatment, with no significant differences between treatment volumes. Following treatment with Rheocarna, blood pressure tends to decrease at f... Although no significant difference was found in the removal rate of Fib and LDL in response to increase volume to 6 L or beyond in this study, the 6 L volume is considered effective enough for the rem...
Magnetic blood purification-based soluble fms-like tyrosine kinase-1 removal in comparison with dextran sulfate apheresis and therapeutic plasma exchange.
Preeclampsia remains one of the most serious complications of pregnancy. Effective therapies are yet to be developed. Recent research has identified an imbalance of angiogenic and antiangiogenic facto... We compare the performance and selectivity of TPE, DSA, and MBP for the therapeutic removal of sFlt-1. For MPB, we employ magnetic nanoparticles functionalized with either sFlt-1 antibodies or the sFl... We demonstrate that sFlt-1 removal by MBP is feasible and significantly more selective than TPE and DSA at comparable sFlt-1 removal efficiencies (MBP 96%, TPE 92%, DSA 78%). During both TPE and DSA, ... Taken together, the highly selective removal of sFlt-1 and potential other disease-causing factors by extracorporeal magnetic blood purification may offer new prospects for preeclamptic patients....
A rare vascular injury in a blood donor after whole blood donation.
Blood donation is a safe process though reactions may still occur. We describe a rare vascular complication in a frequent donor, with improvements in the collection process aimed at avoiding future ev... A 63-year-old woman presented with local pain and an apparent collection in the left arm 8 days after donation. Duplex ultrasound identified a superficial liquid collection and signs of arteriovenous ... Investigation showed a faster whole blood bag collection time (3 min; normal: 5-9 min), and the processed packed red blood cell had a brighter red color than usual. The donor reported local bleeding a... We described an uncommon AP in a donor that was not identified, leading to an AVF that spontaneously thrombosed....
State of the Evidence: Drug Removal via Apheresis.
Therapeutic apheresis refers to a diversity of procedures in which specific hematologic components (e.g., plasma, erythrocytes, leukocytes, etc.) with pathological associations are removed from circul...
Whole blood derived and apheresis platelets: Opinions and preferences-the results of a national survey of blood collectors.
Currently greater than 94% of the US platelet supply is collected by apheresis. A survey to determine the attitudes of members of America's Blood Centers (ABC) toward whole blood derived (WBD) platele... An on-line survey was distributed to medical directors of the 47 ABC members.... Responses were received from 44/47 (94%) ABC members. There were 15/43 (35%) centers that are currently providing WBD platelets. Seventy percent of the respondents agreed or agreed strongly that WBD a... The majority of blood collectors consider WBD platelets clinically equivalent to apheresis, however wider adoption of WBD platelets is still hindered by challenges with logistics and inventory managem...
Primed for change: The effect of a blood prime on peripheral blood stem cell collection and accuracy of a prediction tool in pediatric patients.
Pediatric apheresis collection of peripheral blood stem cells for autologous transplantation often requires use of a blood prime. We evaluated the relationship between pre-apheresis blood CD34...
How do I manage a blood product shortage?
The demand for blood products sometimes exceeds the available inventory. Blood product inventories are dependent upon the availability of donors, supplies and reagents, and collection staff. During pr... The Association for the Advancement of Blood and Biotherapies Donor and Blood Component Management Subsection compiled some strategies from its blood center and hospital transfusion service members th... Some strategies that blood centers could use to increase their available inventories include increasing donor recruitment efforts, using alternate types of collection kits, manufacturing low-yield aph... Blood centers and transfusion services must choose the appropriate strategies to implement based on their needs....
Management of blood transfusion services in low-resource countries.
Enabling universal access to safe blood components should be a key component of every country's national healthcare strategy. This study aimed to assess the current status of infrastructure and resour... A cross-sectional survey was designed to gather information on blood donations, components, redistribution, testing resources and quality management systems (QMSs). The survey was distributed to the I... A total of 54 respondents from 20 countries responded to the survey. This included hospital-based BTS/blood centres (46%), national blood centres (11%)and national and regional blood services (11%). V... QMS was implemented in most of the countries despite the common use of paid donations and the lack of advanced testing. Efforts to overcome persistent challenges and wider implementation of patient bl...
Bioactive components and molecular mechanisms of Salvia miltiorrhiza Bunge in promoting blood circulation to remove blood stasis.
Salvia miltiorrhiza Bunge (SM) is an outstanding herbal medicine with various traditional effects, especially promoting blood circulation to remove blood stasis. It has been widely used for centuries ... To summarize the bioactive components of SM against BSS and highlight its potential targets and signaling pathways, hoping to provide a modern biomedical perspective to understand the efficacy of SM o... A comprehensive literature search was performed to retrieve articles published in the last two decades on bioactive components of SM used for BSS treatment from the online electronic medical literatur... Phenolic acids and tanshinones in SM are the main bioactive components in the treatment of BSS, including but not limited to salvianolic acid B, tanshinone IIA, salvianolic acid A, cryptotanshinone, D... Both phenolic acids and tanshinones in SM may act synergistically to target different signaling pathways to achieve the effect of promoting blood circulation....